Hepatitis B Vaccine Market size was valued at USD 7.9 billion in 2022 and is estimated to reach at USD 11.32 billion in 2030 and grow at a compound annual growth rate approx. CAGR of 4.6% predicted for the forecast period of 2023-2030.
The Hepatitis B vaccine market has witnessed significant growth in recent years, driven by the increasing prevalence of Hepatitis B infections worldwide. Hepatitis B is a viral infection that affects the liver and can lead to chronic liver diseases such as cirrhosis and liver cancer. The vaccine provides effective protection against the virus and is considered a crucial preventive measure.
One of the key factors contributing to the growth of the Hepatitis B vaccine market is the rising awareness about the importance of immunization programs. Governments and healthcare organizations across various countries have been actively promoting vaccination campaigns to control the spread of Hepatitis B. This has resulted in increased demand for vaccines, leading to market expansion.
Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/2976
Furthermore, advancements in vaccine technology have played a vital role in shaping the market landscape. The development of improved formulations, such as combination vaccines that offer protection against multiple diseases, has simplified vaccination schedules and increased patient compliance. Additionally, ongoing research and development efforts are focused on developing more efficient vaccines with enhanced efficacy and longer-lasting immunity.
KEY MARKET SEGMENTS
By Product End-User
- Single Antigen Vaccine
- Combination Vaccine
By End users
- Hospital
- Clinics
- Other
Major Players Listed in the Report are as Follows:
GlaxoSmithKline, Gilead Science Inc., Merck & Co., Inc., Shenzhen Kangtai Biological Products Co., Ltd., Cyrus Poonawalla Group (Serum Institute of India Pvt.), Dynavax, Technologies Corporation, Sanofi, VBI Vaccines Inc., Meiji Group (KM Biologics), LG Chem Ltd., Indian Immunologicals Limited and others
Other Report
Inflammatory Bowel Disease Drugs Market Growth
About US:
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Contact Us:
Akash Anand – Head of Business Development & Strategy,
info@snsinsider.com,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
